Canada
Diabetes country report 2000 — 2050
Skip Map
Number of adults (20–79 years) with diabetes in Canada (CA)
| 2000 | 1.2 million |
| 2011 | 2.7 million |
| 2024 | 2.8 million |
| 2050 | 3.3 million |
Canada is one of the 22 countries and territories in the IDF North America and Caribbean Region. Canada has the third highest number of adults (20-79 years) with diabetes in the Region.
Data source(s) used for the diabetes estimates in adults:
- Canadian Community Health Survey, 2014.
- Hosseini Z., Whiting S.J., Vatanparast H. Appl Physiol Nutr Metab . 2019 Oct;44(10):1099-1104. doi: 10.1139/apnm-2018-0567. Epub 2019 Aug 6.
- Public Health Agency of Canada, Canadian Chronic Disease Surveillance System data files, 2019.
- aijiang Dai, Arwa Younis, Jude Dzevela Kong, Nicola Luigi Bragazzi, Jianhong Wu. JAMA Netw Open. 2021 Aug 2;4(8):e2121443. doi:10.1001/jamanetworkopen.2021.21443. PMID:34410395.
- Government of Canada, National Health Survey. 2021
2000
2011
2024
2050
Loading...
| Diabetes estimates (20-79 y) | ||||
|---|---|---|---|---|
| People with diabetes, in 1,000s | 1,245.5 | 2,716.1 | 2,822.1 | 3,320.2 |
| Age-standardised prevalence of diabetes, % | - | 8.4 | 7.7 | 9.0 |
| Proportion of people with undiagnosed diabetes, % | - | - | 28.9 | - |
| People with undiagnosed diabetes, in 1,000s | - | - | 816.7 | - |
| Impaired Fasting Glucose (IFG) | ||||
|---|---|---|---|---|
| People with IFG, in 1,000s | - | - | 3,834.1 | 4,401.4 |
| Age-standardised prevalence of IFG, % | - | - | 12.2 | 12.8 |
| Impaired Glucose Tolerance (IGT) | ||||
|---|---|---|---|---|
| People with IGT, in 1,000s | - | 3,066.4 | 3,800.4 | 4,384.3 |
| Age-standardised prevalence of IGT, % | - | 10.6 | 11.5 | 12.5 |
| Mortality attributable to diabetes (20-79 y) | ||||
|---|---|---|---|---|
| Deaths attributable to diabetes | - | 17,638.0 | 23,139.8 | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 15.7 | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
|---|---|---|---|---|
| Live births affected by HIP | - | - | 47,794.1 | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | 11.8 | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | 1,951.0 | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | 4,790.4 | - |
| Diabetes-related health expenditure | ||||
|---|---|---|---|---|
| Total diabetes-related health expenditure, USD million | - | - | 13,737.3 | 14,682.9 |
| Total diabetes-related health expenditure, ID million | - | - | 14,301.3 | 15,285.8 |
| Diabetes-related health expenditure per person, USD | - | 5,106.0 | 4,867.8 | 4,422.4 |
| Diabetes-related health expenditure per person, ID | - | - | 5,067.7 | 4,603.9 |
| Type 1 diabetes estimates in children and adolescents | ||||
|---|---|---|---|---|
| People with type 1 diabetes (all age groups) | - | - | 243,390.0 | - |
| People with type 1 diabetes (0-19 y) | - | - | 27,641.8 | - |
| Demographics | ||||
|---|---|---|---|---|
| Total adult population (20-79 y), in 1,000s | 21,389.0 | 25,140.9 | 29,115.3 | 32,592.4 |
| Population of children and adolescents (0-19 y) | - | - | 8,181,766.5 | - |
Loading...
| Diabetes estimates (20-79 y) | |
|---|---|
| People with diabetes, in 1,000s | 1,245.5 |
| Age-standardised prevalence of diabetes, % | - |
| Proportion of people with undiagnosed diabetes, % | - |
| People with undiagnosed diabetes, in 1,000s | - |
| Impaired Fasting Glucose (IFG) | |
|---|---|
| People with IFG, in 1,000s | - |
| Age-standardised prevalence of IFG, % | - |
| Impaired Glucose Tolerance (IGT) | |
|---|---|
| People with IGT, in 1,000s | - |
| Age-standardised prevalence of IGT, % | - |
| Mortality attributable to diabetes (20-79 y) | |
|---|---|
| Deaths attributable to diabetes | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
|---|---|
| Live births affected by HIP | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - |
| Live births affected by other types of diabetes first detected in pregnancy | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - |
| Diabetes-related health expenditure | |
|---|---|
| Total diabetes-related health expenditure, USD million | - |
| Total diabetes-related health expenditure, ID million | - |
| Diabetes-related health expenditure per person, USD | - |
| Diabetes-related health expenditure per person, ID | - |
| Type 1 diabetes estimates in children and adolescents | |
|---|---|
| People with type 1 diabetes (all age groups) | - |
| People with type 1 diabetes (0-19 y) | - |
| Demographics | |
|---|---|
| Total adult population (20-79 y), in 1,000s | 21,389.0 |
| Population of children and adolescents (0-19 y) | - |
